Choose A Year - 2008 Grant Recipients

2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004


2008 Senior Research Award


David Avigan, M.D.
Beth Israel Deaconess Medical Center, Boston, MA
"Vaccination and T cell therapy Using DC/Myeloma fusions with Transplant"

Ralf Bargou, M.D.
University of Wurzburg, Wurzburg, Germany
"Overcoming drug resistance in MM: development of an in vivo mouse model"

Ruben Carrasco, M.D.
Dana-Farber Cancer Institute, Boston, MA
"Targeting Wnt Signaling in Myeloma Using Stabilized Alpha-Helices of BCL9"

Marta Chesi, Ph.D.
Mayo Clinic, Scottsdale, AZ
"Comparative oncogenomic to identify myeloma progression events"

Alfred Goldberg, Ph.D.
Harvard Medical School, Boston, MA
"Development of Novel Types of Proteasome Inhibitors that Regulate Substrate"

Lori Hazlehurst, Ph.D.
H. Lee Moffitt Cancer Center, Tampa, FL
"Beta 1 integrin inhibitory peptides: Novel agents for the treatment of MM"

Constantine Mitsiades, M.D., Ph.D.
Dana-Farber Cancer Center, Boston, MA
"Erastin analogs as anti-myeloma agentswth Factor for Treatment of Myeloma"

Shigeki Miyamoto, Ph.D.
University of Wisconsin, Madison, WI
"Targeting a third NF-KB pathway for anti-myeloma drug development"

Jetze Tepe, Ph.D.
Michigan State University, East Lansing, MI
"Phosphoproteomic Analysis of NF-kappaB in MMquot;

Qing Yi, M.D., Ph.D.
M.D. Anderson Cancer Center, Houston, TX
"Anti-b2M monoclonal antibodies as therapeutic agent for myeloma"

Fenghuang Zhan, M.D., Ph.D.
University of Arkansas for Medical Sciences, Little Rock, AR
"Define CKS1B signaling pathways in myeloma: therapeutic implication"

2008 Research Fellow Award


Abdel Kareem Azab, Ph.D.
Dana-Farber Cancer Institute
"The Role of Selectins in Multiple Myeloma"

Tsui-Fen Chou, Ph.D.
California Institute of Technology
"Evaluation of p97 as a Potential Target in Multiple Myeloma"

Alex Klimowicz, Ph.D.
University of Calgary
"Tissue-Based Array Classification of Multiple Myeloma"

Eva Martinez, Ph.D.
Northwestern University
"Epigenetic Deregulation by the Multiple Myeloma SET Domain Protein"

Rao Prabhala, Ph.D.
Boston VA Research Institute
"TH17 Cytokines in Myeloma: Immunotherapeutic Targets"

Wei Xiong, Ph.D.
University of Utah
"Investigation of TP53-Regulated MicroRNAs and mRNAs in Multiple Myeloma"

Eyal Zcharia, Ph.D.
Hadassah Medical Organization
"Heparanase as a Target for Myeloma Treatment"

2008 Validation of Novel Combinations and Novel Compounds


Donald Kufe, M.D.
Dana-Farber Cancer Institute
"Tareting the MUC1 Oncoprotein in MM"

Noopur Raje, M.D.
Massachusetts General Hospital
"RAP-011, A Novel Activin Antagonist in the Treatment of MM"

Terry Landowski, Ph.D.
University of Arizona
"Inhibition of the Autophagic Survival Response to Enhance Chemotherapy"

Hsiou-Chi Liou, Ph.D.
Weill Cornell Medical College
"Validation of Pyrimidinetriones as Potential Therapy for MM"

Simon Joel, Ph.D.
Barts and the London School of Medicine
"The Activity of Novel P13K Inhibitors in MM"

Dharminder Chauhan, M.D.
Dana-Farber Cancer Institute
"Targeting Deubiquitylase Enzyme USP-7 as Therapy in MM"

Wim Vanden Berghe, Ph.D.
University of Ghent
"Validation of Withaferin A as an Anti-Myeloma Compound"

Cancer Stem Cell Initiative
Jointly-sponsored by The Multiple Myeloma Research Foundation and The Leukemia & Lymphoma Society


William H. Matsui, M.D.
Johns Hopkins University
"Functional Analysis of Clonogenic Myeloma Growth"

Irving L. Weissman, M.D.
Stanford University
"Prospective Identification of Multiple Myeloma Stem Cells"